线状IgA大疱性皮病的研究进展

doi:10.35541/cjd.20200496

Abstract

Jing Ke, Li Suo, Feng Suying. Linear IgA bullous dermatosis[J]. Chinese Journal of Dermatology, 2022, 55(10): 925-928.doi:10.35541/cjd.20200496

References ［33］

［1］	Lammer J, Hein R, Roenneberg S, et al. Drug⁃induced linear IgA bullous dermatosis: a case report and review of the literature［J］. Acta Derm Venereol, 2019,99（6）:508⁃515. doi: 10.2340/00015 555⁃3154.
［2］	Fortuna G, Marinkovich MP. Linear immunoglobulin A bullous dermatosis［J］. Clin Dermatol, 2012,30（1）:38⁃50. doi: 10.1016/j.clindermatol.2011.03.008.
［3］	Tsuchisaka A, Ohara K, Ishii N, et al. Type VII collagen is the major autoantigen for sublamina densa⁃type linear IgA bullous dermatosis［J］. J Invest Dermatol, 2015,135（2）:626⁃629. doi: 10.1038/jid.2014.381.
［4］	Cozzani E, Di Zenzo G, Gasparini G, et al. Autoantibody profile of a cohort of 54 Italian patients with linear IgA bullous dermatosis: LAD⁃1 denoted as a major auto⁃antigen of the lamina lucida subtype［J］. Acta Derm Venereol, 2020,100（4）:adv00070. doi: 10.2340/00015555⁃3415.
［5］	Edwards G, Diercks G, Seelen M, et al. Complement activation in autoimmune bullous dermatoses: a comprehensive review［J］. Front Immunol, 2019,10:1477. doi: 10.3389/fimmu.2019.01477.
［6］	Hoffmann J, Hadaschik E, Enk A, et al. Linear IgA bullous dermatosis secondary to infliximab therapy in a patient with ulcerative colitis［J］. Dermatology, 2015,231（2）:112⁃115. doi: 10.1159/000431172.
［7］	Riemenschneider K, Diiorio DA, Zic JA, et al. Drug⁃induced linear IgA bullous dermatosis in a patient with a vancomycin⁃impregnated cement spacer［J］. Cutis, 2018,101（4）:293⁃296.
［8］	Tadiotto Cicogna G, Ferranti M, Vaccari D, et al. Topical imiquimod⁃induced linear IgA bullous dermatosis［J］. BMJ Case Rep, 2019,12（7）:e230037. doi: 10.1136/bcr⁃2019⁃230037.
［9］	Tiger JB, Rush JT, Barton DT, et al. Urticarial linear IgA bullous dermatosis （LABD） as a presenting sign of chronic lymphocytic leukemia （CLL）［J］. JAAD Case Rep, 2015,1（6）:412⁃414. doi: 10.1016/j.jdcr.2015.10.001.
［10］	Colmant C, Camboni A, Dekeuleneer V, et al. Linear IgA dermatosis in association with angioimmunoblastic T⁃cell lymphoma infiltrating the skin: a case report with literature review［J］. J Cutan Pathol, 2020,47（3）:251⁃256. doi: 10.1111/cup.13576.
［11］	Kanda N, Nakadaira N, Otsuka Y, et al. Linear IgA bullous dermatosis associated with ulcerative colitis: a case report and literature review［J］. Australas J Dermatol, 2020,61（1）:e82⁃e86. doi: 10.1111/ajd.13121.
［12］	Malipatel R, Gnanapriya V, Manocha A, et al. Systemic lupus erythematosus with linear IgA bullous dermatosis and renal vascular lesions: an extremely rare association［J］. Indian J Nephrol, 2018,28（6）:465⁃467. doi: 10.4103/ijn.IJN_200_17.
［13］	Tieppo Francio V, Towery C, Davani S, et al. Previously misdiagnosed linear IgA dermatosis resolved with dapsone［J］. BMJ Case Rep, 2018,2018:bcr2017220623. doi: 10.1136/bcr⁃2017⁃220623.
［14］	Ikkaku N, Tateishi C, Oda Y, et al. Linear immunoglobulin A bullous dermatosis developing during late pregnancy［J］. J Dermatol, 2017,44（3）:e44⁃e45. doi: 10.1111/1346⁃8138.13475.
［15］	陈吉辉, 苟辉, 张敏, 等. 妊娠期并发成人型线状IgA大疱性皮病1例报告［J］. 四川大学学报（医学版）, 2019,50（2）:288.
［16］	Shetty VM, Pai SB, Rao R. Linear IgA bullous dermatosis presenting as chronic prurigo: unveiling of the diagnosis by serrated pattern analysis［J］. Int J Dermatol, 2018,57（11）:e147⁃e149. doi: 10.1111/ijd.14253.
［17］	Vives Ricoma E, El Uali Abeida M, Viso Soriano MJ, et al. Linear IgA bullous dermatosis with laryngeal involvement［J］. Acta Otorrinolaringol Esp, 2020,71（3）:190⁃192. doi: 10.1016/j.otorri.2019.05.006.
［18］	Shah S, Mohr B, Parekh P. Linear IgA bullous dermatosis mimicking oral lichen planus［J］. Proc （Bayl Univ Med Cent）, 2017,30（3）:360⁃361. doi: 10.1080/08998280.2017.11929649.
［19］	Wang H, Wang X, Yang B, et al. Image gallery: onychomadesis in linear IgA bullous dermatosis［J］. Br J Dermatol, 2020,182（5）:e160. doi: 10.1111/bjd.18744.
［20］	Choudhry SZ, Kashat M, Lim HW. Vancomycin⁃induced linear IgA bullous dermatosis demonstrating the isomorphic phenomenon［J］. Int J Dermatol, 2015,54（11）:1211⁃1213. doi: 10.1111/ijd.12944.
［21］	Mesa⁃Álvarez L, Peón Currás G, Flórez Á. Widespread erythematous and bullous plaques associated with nasolabial fold ulceration: answer［J］. Am J Dermatopathol, 2019,41（3）:237⁃238. doi: 10.1097/DAD.0000000000001051.
［22］	Nguyen JK, Koshelev MV, Gill BJ, et al. A toxic epidermal necrolysis⁃like presentation of linear IgA bullous dermatosis treated with dapsone［J］. Dermatol Online J, 2017,23（8）:13030/qt4443157h.
［23］	Helmandollar KJ, Hoverson KR, Falkner RC, et al. Diffuse vesiculobullous eruption with systemic findings［J］. Dermatol Online J, 2018,24（5）:13030/qt09m1x0c1.
［24］	Fulton E, Jan F, Zimarowski MJ. Flame figures in linear IgA bullous dermatosis: a novel histopathologic finding［J］. Dermatol Online J, 2017,23（11）:13030/qt1qs7m39f.
［25］	Díaz MS, Morita L, Ferrari B, et al. Linear IgA bullous dermatosis: a series of 17 cases［J］. Actas Dermosifiliogr, 2019,110（8）:673⁃680. doi: 10.1016/j.ad.2018.06.017.
［26］	Ohata C, Ishii N, Koga H, et al. A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence［J］. Br J Dermatol, 2017,177（1）:152⁃157. doi: 10.1111/bjd.15232.
［27］	Shan XF, Zhang FR, Tian HQ, et al. A case of linear IgA dermatosis successfully treated with tetracycline and niacinamide［J］. Int J Dermatol, 2016,55（4）:e216⁃e217. doi: 10.1111/ijd. 12524.
［28］	Cui YX, Yang BQ, Zhou GZ, et al. Childhood linear IgA bullous dermatosis successfully treated with oral nicotinamide［J］. Clin Exp Dermatol, 2016,41（7）:816⁃818. doi: 10.1111/ced.12892.
［29］	Kaya İslamoğlu ZG, Akyürek FT. A case of recalcitrant linear IgA bullous dermatosis: successfully treated with rituximab［J］. Dermatol Ther, 2019,32（3）:e12911. doi: 10.1111/dth.12911.
［30］	Lamberts A, Euverman HI, Terra JB, et al. Effectiveness and safety of rituximab in recalcitrant pemphigoid diseases［J］. Front Immunol, 2018,9:248. doi: 10.3389/fimmu.2018.00248.
［31］	Maalouf NS, Hanna D. Linear IgA bullous dermatosis successfully treated with omalizumab: a case report［J］. JAAD Case Rep, 2019,5（11）:966⁃969. doi: 10.1016/j.jdcr.2019.08.019.
［32］	Yamada S, Makino T, Jinnin M, et al. Association of linear IgA bullous disease with ulcerative colitis: a case of successful treatment with infliximab［J］. Dermatology, 2013,227（4）:295⁃298. doi: 10.1159/000355354.
［33］	Legendre L, Maza A, Almalki A, et al. Botulinum toxin a: an effective treatment for linear immunoglobulin A bullous dermatosis located in the axillae［J］. Acta Derm Venereol, 2016,96（1）:122⁃123. doi: 10.2340/00015555⁃2178.

[1]	Gao Zirui, Zhao Pei, Dou Yuanqing, Liu Ping, Zhang Jianzhong. Efficacy and safety of dupilumab in the treatment of adult prurigo nodularis [J]. Chinese Journal of Dermatology, 2022, 55(7): 562-565.
[2]	Wang Lingyan, Pan Jing, Miao Gang, Chang Xiaodan, Jin Qiuzi, Guo Ningning, Zhang Jiayu. Analysis of difficult-to-treat sites in patients with psoriasis who received biological therapy [J]. Chinese Journal of Dermatology, 2022, 55(7): 583-587.
[3]	Lyu Sha, Wang Shuang, Wu Hanfei, Zhang Mingrui, Hu Xin, Li Fuqiu. Research progress in sporotrichosis [J]. Chinese Journal of Dermatology, 2022, 55(7): 629-632.
[4]	Huang Xin, Chen Xiaoyun, Li Yaping, Liang Xingkun, Zhang Guiying, Zhou Ying, Zhan Yi, Luo Shuaihantian, Liao Jieyue, Xiao Rong, Long Hai. Efficacy and safety of dupilumab in the treatment of 123 cases of atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(6): 486-493.
[5]	Hu Yebei, Song Xiuzu. Tranexamic acid for the treatment of melasma [J]. Chinese Journal of Dermatology, 2022, 55(5): 460-462.
[6]	Centre for Urticaria Research, Chinese Society of Dermatology. Guidelines for education of patients with chronic urticaria [J]. Chinese Journal of Dermatology, 2022, 0(4): 20220305-e20220305.
[7]	Li Yan, Li Ming, Xu Wei, Li Linfeng. Calcium-based antimicrobial peptide compounds cooling gel for the treatment of atopic dermatitis: a randomized, double-blind controlled clinical study [J]. Chinese Journal of Dermatology, 2022, 55(4): 345-348.
[8]	Liu Bo, Song Xiaoting, Liao Shuanglu, Yu Miao, Luan Tingting, Li Ruoyu, Zhao Zuotao. Efficacy and safety of baricitinib in the treatment of moderate-to-severe atopic dermatitis: a clinical observation [J]. Chinese Journal of Dermatology, 2022, 55(4): 304-307.
[9]	Li Hao, Wang Li, Han Xianwei, Sun Tong, Su Fang, Sun Xiaodong, Han Ying, Yang Guoling, Liu Xiaoming, Wang Kaibo. Analysis of clinical characteristics of bullous pemphigoid developing after the treatment with dipeptidyl peptidase-Ⅳ inhibitors in 32 patients with diabetes mellitus [J]. Chinese Journal of Dermatology, 2022, 55(3): 213-218.
[10]	Wang Juanjuan, Chen Rong, Ji Jiang, Su Wenxing, Wei Yuqian, Zhao Ying, Yin Xingping, Su Yuhua, Shi Xin. Retrospective analysis of 67 cases of neurosyphilis with abnormal mental behaviors as the initial symptom [J]. Chinese Journal of Dermatology, 2022, 55(3): 231-234.
[11]	Li Yan, Li Ming, Xu Wei, Li Linfeng. Efficacy of fluticasone propionate cream alone or in combination with calcipotriol ointment in the treatment of mild to moderate plaque psoriasis: a randomized self-controlled study [J]. Chinese Journal of Dermatology, 2022, 55(3): 260-263.
[12]	Li Sai, Xue Huazhong, Zhang Shuwen, Jiang Juan, Qi Shuzhen, Zhao Yuanyuan, Zhang Jinping, Sha Zhong, Le Wenjing, Wang Biwei, Zhao Shixuan, Zhu Xiaofeng, Su Xiaohong. Doxycycline-moxifloxacin sequential therapy for Mycoplasma genitalium urethritis/cervicitis: a clinical observation [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210631-e20210631.
[13]	Wang Jiaqi, Wang Ping, Li Liuyu, Fan Qimin, Zhu Mengyan, Wang Yanqing, Zhou Hongyu, Shen Hong, Xu Ai′e. Cutaneous hypopigmented lymphoproliferative disorders: a clinicopathological study of 41 cases [J]. Chinese Journal of Dermatology, 2022, 55(2): 110-115.
[14]	Yin Guangwen, Geng Mengmeng, Cui Yan, Zhang Shoumin, Li Dongqin, Cheng Xiuyong. The first case of neonatal linear IgA bullous dermatosis in China mainland [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210502-e20210502.
[15]	Sun Jing, Xu Yingnan, Lin Tong, Xue Jinsong. Analysis of clinical treatment outcomes of ocular lesions in 28 cases of severe ocular rosacea [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210755-e20210755.

Linear IgA bullous dermatosis

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［33］

Related Articles 15

Metrics

Comments

Recommended 10